17:57 , May 16, 2017 |  BC Innovations  |  Distillery Techniques

Biomarkers

TECHNOLOGY: Gene profiling Tumor levels of eight proteins could help predict survival in melanoma. In patients, low tumor levels of eight tumor suppressors -- tumor necrosis factor α-induced protein 3 ( TNFAIP3 ; A20), PR...
19:37 , Dec 6, 2016 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Staphylococcus Cell culture experiments suggest inhibiting bacterial sufA , sufC and other FeS cluster assembly proteins could help treat bone, skin and other infections caused by anaerobic Staphylococcus aureus . In bacterial cultures, a...
07:00 , Oct 2, 2006 |  BioCentury  |  Tools & Techniques

Targeting fibrosis

Haptogen Ltd. was expected to announce on Monday this week that it has preclinical proof of principle for an antibody that can be used both to image early stage liver damage in vivo, and to...
07:00 , May 15, 2006 |  BioCentury  |  Strategy

Next-generation protein players

Next-generation protein players Company Platform 4-Antibody Uses genetically modified preB cells, which can develop into human antibody producing cells, to generate optimized antibodies Ablynx Developing nanobodies, or single-domain antibodies, which combine advantages of antibody therapeutics...
07:00 , Oct 25, 2004 |  BioCentury  |  Finance

Ebb & Flow

A flurry of listings on AIM this month has been driven by a set of investors that differs significantly from investors in the types of biotech companies that would list on the main London market....
07:00 , May 13, 2004 |  BC Extra  |  Company News

Evotec, Guilford discovery deal

GLFD and Evotec OAI (FES:EVT) partnered to develop small molecules against GLFD targets. EVT will develop assays and perform ultra-high throughput screening to identify compounds. EVT also will characterize selected hits. EVT will receive research...
08:00 , Dec 8, 2003 |  BC Week In Review  |  Company News

Artemis, Bayer deal

Artemis will use its ArteMice technology to produce genetically engineered mice for BAYG. The pharma company will use the mice in its gene function analysis research and for compound testing. Artemis is a subsidiary of...